Oncology & Cancer

A closer look at the impact of COVID-19 on cardio-oncology

Cancer survivors have an increased risk of mortality from heart failure, coronary heart disease, and stroke. Lauren Baldassarre, MD, serves as the director of the Yale Cardio-Oncology program, which seeks to prevent and treat ...

Oncology & Cancer

Host immune classifier HIC assays may predict treatment response

Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International ...

Oncology & Cancer

Black lung cancer patients die sooner than white counterparts

Structural racism thwarts a large proportion of black patients from receiving appropriate lung cancer care, resulting in worse outcomes and shorter lifespans than white patients with the disease, according to research presented ...

Oncology & Cancer

Global demand for cancer surgery set to surge

Public health researchers, led by UNSW Sydney, have estimated the number of cancer cases requiring surgery globally each year, predicting the number will rise from 9.1 million to 13.8 million from 2018 to 2040—an increase ...

Oncology & Cancer

Q&A: Genetic abnormalities and cancer risk

My mom was diagnosed with breast cancer. During her care, she was found to have a BRCA2 mutation. Her doctor suggested that my brothers and I get tested for this mutation, too. I am a 26-year-old woman, and I am not sure ...

Oncology & Cancer

Routine thoracic surgery safe during COVID-19 pandemic

A study in the Journal of Thoracic Oncology (JTO) comparing surgeries performed at one Chinese hospital in 2019 with a similar date range during the COVID-19 pandemic found that routine thoracic surgery and invasive examinations ...

page 2 from 40